Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Specifically it is used for NSCLC with either an EGFR exon 19 deletion (del19) or exon 21 (L858R) substitution mutation which has spread to other parts of the body.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Erlotinib brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Erlotinib medicine cost price in India.
The order for Erlotinib will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
TARCEVA® (erlotinib) tablets, oral Initial U.S. Approval: 2004
Generic Name: Erlotinib
Tablets: 25 mg, 100 mg and 150 mg.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Erlotinib on prescription and Import License in Patient's Name only.
For overseas patients, Erlotinib can be made available in Send your enquiry to find Erlotinib in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Erlotinib Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Shilpa Medicare gets US FDA nod for its ANDA, Erlotinib tablets For More Details
FDA approves first-line Tecentriq plus chemotherapy for metastatic nonsquamous non-small cell lung cancer For More Details